Steinar Aamdal

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson et al. · Journal of Clinical Oncology · 2000 · 1.3K citations

Pharmacy, Oncology, Pharmacokinetics +12

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine · 2011 · 531 citations · Full text

Medicine, Immunology, Oncology +17

Cisplatin and Etoposide Regimen Is Superior to Cyclophosphamide, Epirubicin, and Vincristine Regimen in Small-Cell Lung Cancer: Results From a Randomized Phase III Trial With 5 Years’ Follow-Up

Stein Sundstrøm, Roy M. Bremnes, Stein Kaasa et al. · Journal of Clinical Oncology · 2002 · 504 citations

Medicine, Oncology, Pharmacology +9

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob et al. · Journal of Clinical Oncology · 2004 · 474 citations

Medicine, Oncology, Pharmacology +10

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

Michele Maio, Jean‐Jacques Grob, Steinar Aamdal et al. · Journal of Clinical Oncology · 2015 · 471 citations · Full text

Medicine, Oncology, Pharmacotherapy +14